Edition:
United States

Pieris Pharmaceuticals Inc (PIRS.OQ)

PIRS.OQ on NASDAQ Stock Exchange Capital Market

2.94USD
4:00pm EDT
Change (% chg)

$0.03 (+1.03%)
Prev Close
$2.91
Open
$2.91
Day's High
$2.95
Day's Low
$2.84
Volume
44,586
Avg. Vol
94,337
52-wk High
$6.91
52-wk Low
$2.40

About

Pieris Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company's pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled asthma and a half-life-optimized Anticalin to treat anemia. Its Anticalins proteins are a class of low... (more)

Overall

Beta: 1.78
Market Cap(Mil.): $143.03
Shares Outstanding(Mil.): 49.15
Dividend: --
Yield (%): --

Financials

  PIRS.OQ Industry Sector
P/E (TTM): -- 109.42 62.41
EPS (TTM): -0.51 -- --
ROI: -35.35 7.98 11.81
ROE: -103.98 8.13 12.64

Earnings vs. Estimates